These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3111515)

  • 1. Cyclophosphamide priming reduces intestinal damage in man following high dose melphalan chemotherapy.
    Selby PJ; Lopes N; Mundy J; Crofts M; Millar JL; McElwain TJ
    Br J Cancer; 1987 May; 55(5):531-3. PubMed ID: 3111515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut protection by cyclophosphamide "priming" in patients receiving high-dose melphalan--effect of drug scheduling.
    Mansi J; Ellis E; Viner C; Mundy J; Smith T; Millar J; Milan S; Gore M; Cunningham D
    Cancer Chemother Pharmacol; 1992; 30(2):149-51. PubMed ID: 1600595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantation.
    Cornbleet MA; McElwain TJ; Kumar PJ; Filshie J; Selby P; Carter RL; Hedley DW; Clark ML; Millar JL
    Br J Cancer; 1983 Sep; 48(3):329-34. PubMed ID: 6351883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose melphalan with autologous bone marrow transplant. Treatment of poor prognosis tumors.
    Corringham R; Gilmore M; Prentice HG; Boesen E
    Cancer; 1983 Nov; 52(10):1783-7. PubMed ID: 6354413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal permeability to 51Cr-EDTA in rats with experimentally induced enteropathy.
    Bjarnason I; Smethurst P; Levi AJ; Peters TJ
    Gut; 1985 Jun; 26(6):579-85. PubMed ID: 3924747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I.v. melphalan in carcinoma of the lung: effect of cyclophosphamide priming on hematopoietic toxicity.
    Spitzer G; Valdivieso M; Farha P; Murphy WK; Dhingra HM; Chiuten D; Umsawasdi T; Holoye P
    Cancer Treat Rep; 1986 Apr; 70(4):449-53. PubMed ID: 3698037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors.
    Mulder PO; Sleijfer DT; Willemse PH; de Vries EG; Uges DR; Mulder NH
    Cancer Res; 1989 Aug; 49(16):4654-8. PubMed ID: 2545349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer.
    Lazarus HM; Herzig RH; Graham-Pole J; Wolff SN; Phillips GL; Strandjord S; Hurd D; Forman W; Gordon EM; Coccia P
    J Clin Oncol; 1983 Jun; 1(6):359-67. PubMed ID: 6366139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin.
    Ayash LJ; Elias A; Schwartz G; Wheeler C; Ibrahim J; Teicher BA; Reich E; Warren D; Lynch C; Richardson P; Schnipper L; Frei E; Antman K
    J Clin Oncol; 1996 Nov; 14(11):2984-92. PubMed ID: 8918496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide pretreatment reduces the toxic effect of high dose melphalan on intestinal epithelium in sheep.
    Millar JL; Phelps TA; Carter RL; McElwain TJ
    Eur J Cancer (1965); 1978 Nov; 14(11):1283-5. PubMed ID: 738333
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of high-dose melphalan on marrow and intestinal epithelium in mice pretreated with cyclophosphamide.
    Millar JL; Hudspith BN; McElwain TJ; Phelps TA
    Br J Cancer; 1978 Jul; 38(1):137-42. PubMed ID: 687511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma.
    Pritchard J; McElwain TJ; Graham-Pole J
    Br J Cancer; 1982 Jan; 45(1):86-94. PubMed ID: 7037033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose melphalan with autologous marrow rescue in cancer treatment.
    Dewar JM; Forgeson GV; Dady PJ
    N Z Med J; 1984 Nov; 97(768):816-8. PubMed ID: 6390271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 51Cr-EDTA absorption blood test: an easy method for assessing small intestinal permeability in dogs.
    Frias R; Sankari S; Westermarck E
    J Vet Intern Med; 2004; 18(2):156-9. PubMed ID: 15058765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
    Valteau-Couanet D; Vassal G; Pondarré C; Bonnay M; Benhamou E; Couanet D; Plantaz D; Hartmann O
    Bone Marrow Transplant; 1996 Apr; 17(4):485-9. PubMed ID: 8722343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Ewing's sarcoma with high-dose melphalan and autologous bone marrow transplantation.
    Cornbleet MA; Corringham RE; Prentice HG; Boesen EM; McElwain TJ
    Cancer Treat Rep; 1981; 65(3-4):241-4. PubMed ID: 7016319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission.
    Helenglass G; Powles RL; McElwain TJ; Lakhani A; Milan S; Gore M; Nandi A; Zuiable A; Perren T; Forgeson G
    Bone Marrow Transplant; 1988 Jan; 3(1):21-9. PubMed ID: 3048467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose melphalan with autologous bone marrow rescue for the treatment of advanced adult solid tumors.
    Maraninchi D; Abecasis M; Gastaut JA; Herve P; Sebahoun G; Flesch M; Blanc AP; Carcassonne Y
    Cancer Treat Rep; 1984 Mar; 68(3):471-4. PubMed ID: 6367977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceleration of bone-marrow recovery by pre-treatment with cyclophosphamide in patients receiving high-dose melphalan.
    Hedley DW; McElwain TJ; Millar JL; Gordon MY
    Lancet; 1978 Nov; 2(8097):966-8. PubMed ID: 81990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.